- Home
- FENC vs DBI Comparison
FENC vs DBI Comparison
Compare FENC & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- DBI
- Stock Information
- Founded
- FENC 1996
- DBI 1991
- Country
- FENC United States
- DBI United States
- Employees
- FENC N/A
- DBI N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- DBI Clothing/Shoe/Accessory Stores
- Sector
- FENC Health Care
- DBI Consumer Discretionary
- Exchange
- FENC Nasdaq
- DBI Nasdaq
- Market Cap
- FENC 156.9M
- DBI 178.0M
- IPO Year
- FENC 2001
- DBI 1991
- Fundamental
- Price
- FENC $8.07
- DBI $3.34
- Analyst Decision
- FENC Strong Buy
- DBI Hold
- Analyst Count
- FENC 2
- DBI 2
- Target Price
- FENC $13.00
- DBI $4.75
- AVG Volume (30 Days)
- FENC 105.2K
- DBI 1.1M
- Earning Date
- FENC 05-13-2025
- DBI 06-10-2025
- Dividend Yield
- FENC N/A
- DBI 5.63%
- EPS Growth
- FENC N/A
- DBI N/A
- EPS
- FENC N/A
- DBI N/A
- Revenue
- FENC $30,912,000.00
- DBI $3,009,262,000.00
- Revenue This Year
- FENC N/A
- DBI $2.22
- Revenue Next Year
- FENC $58.65
- DBI $2.18
- P/E Ratio
- FENC N/A
- DBI N/A
- Revenue Growth
- FENC N/A
- DBI N/A
- 52 Week Low
- FENC $3.96
- DBI $2.44
- 52 Week High
- FENC $8.56
- DBI $11.06
- Technical
- Relative Strength Index (RSI)
- FENC 66.93
- DBI 52.70
- Support Level
- FENC $7.79
- DBI $3.10
- Resistance Level
- FENC $8.34
- DBI $3.82
- Average True Range (ATR)
- FENC 0.46
- DBI 0.20
- MACD
- FENC 0.06
- DBI 0.01
- Stochastic Oscillator
- FENC 76.75
- DBI 48.65
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.